Multi-university TTO Satt Sud-Est has licensed patents to GenOmnis for an RNA-based bioinformatics technology that will assess the pathogenicity of biological organisms.
Regional tech transfer office Satt Sud-Est has licensed patents jointly owned by Aix-Marseille Université, research institute Inserm and hospital operator Assistance Publique – Hôpitaux de Marseille (AP-HM) to France-based bioinformatics company GenOmnis.
Founded in 2017, GenOmnis provides bioinformatic services such as genomics and genetic testing to hospitals, diagnostic laboratories and drug developers.
The new licence covers a bioinformatics technology that applies high-throughput RNA sequencing and well-calibrated algorithms to help researchers gauge the likelihood of biological organisms causing disease.